These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 36271288

  • 1. Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test.
    Iwamoto Y, Tatsumi F, Itoh T, Sasaki T, Mori S, Sugisaki T, Nakao E, Ohnishi M, Kusano T, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Kimura T, Shimoda M, Nakanishi S, Kaku K, Mune T, Kaneto H.
    Sci Rep; 2022 Oct 21; 12(1):17680. PubMed ID: 36271288
    [Abstract] [Full Text] [Related]

  • 2. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S, Vasiliou V, Kokkoris P, Stavropoulos G, Thalassinos N.
    Clin Endocrinol (Oxf); 1999 Oct 21; 51(4):473-7. PubMed ID: 10583315
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun 21; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB.
    J Clin Endocrinol Metab; 1994 Feb 21; 78(2):418-22. PubMed ID: 8106630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M, Elias LL, Elias PC, Moreira AC.
    Clin Endocrinol (Oxf); 2003 Dec 21; 59(6):800-5. PubMed ID: 14974925
    [Abstract] [Full Text] [Related]

  • 8. [Clinical features and outcomes of surgical versus conservative management in patients with subclinical Cushing's syndrome].
    Liu MS, Zhang WJ, Zhu KY, Feng WH, Huang H, Zhu DL, Li P.
    Zhonghua Yi Xue Za Zhi; 2020 Sep 29; 100(36):2834-2840. PubMed ID: 32988143
    [Abstract] [Full Text] [Related]

  • 9. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May 29; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 10. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T.
    Endocr J; 2018 Apr 26; 65(4):383-393. PubMed ID: 29576599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov 26; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP, de Herder WW, de Jong FH, Biemond P, van der Lely AJ, Lamberts SW.
    Clin Endocrinol (Oxf); 1999 Aug 26; 51(2):193-8. PubMed ID: 10468990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA, Cutler GB, Chrousos GP, Nieman LK.
    JAMA; 1993 May 05; 269(17):2232-8. PubMed ID: 8386285
    [Abstract] [Full Text] [Related]

  • 17. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N, Diederich S, Oelkers W.
    Clin Endocrinol (Oxf); 1998 Jan 05; 48(1):45-51. PubMed ID: 9509067
    [Abstract] [Full Text] [Related]

  • 18. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar 05; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 19. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct 05; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.